DBAWvsIBRN
XTRACKERS MSCI ALL WORLD EX US HEDGED EQUITY ETF against iShares Neuroscience and Healthcare ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| DBAW | IBRN | |
|---|---|---|
| Expense ratio | — | 0.47% |
| Assets | $134M | $6640.17T |
| Net flow, 1 month | — | −$60K |
| Net flow, 1 year | — | +$2M |
| Return, YTD | +15.8% | +1.7% |
| Return, 1 year | +20.3% | +22.3% |
| Avg daily volume | 22K | 2K |
| Holdings | 1958 | 54 |
| Listed | Jun 8, 2024 | Aug 24, 2022 |
| Options market | No | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS